Connect
Discussion
Comment receiving replies
Replies to "Could be not sure… however, the chemical they’re using is called LUTETIUM – 177. I believe..."
Prostate Cancer | Last Active: Sep 26 3:50pm | Replies (21)
Comment receiving replies
Could be not sure… however, the chemical they’re using is called LUTETIUM – 177. I believe it’s the radioactive shot to give you every six weeks for metastatic prostate cancer that is not castrate resistant.
Replies to "Could be not sure… however, the chemical they’re using is called LUTETIUM – 177. I believe..."
@whatthef Lu 177 is Pluvicto. If you search the posts on "Pluvicto," you can read many entries that should answer your questions.
@whatthef Also, it is an infusion, not a shot, and it can be given to both castrate sensitive and castrate resistant men.
Connect
@whatthef - Yep, that's Pluvicto. PSMAddition was a trial specifically adding Pluvicto to ARPI. The recent FDA approval your Dr is referring to (7/31/26) is for castrate sensitive patients. Pluvicto was already approved for castrate resistant disease.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01092-5/abstract
https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/170879-fda-approves-pluvicto-for-psma-positive-metastatic-hormone-sensitive-prostate-cancer-mhspc.html